Blocking the interaction with CD30 using an anti-CD153 antibody inhibits the age-related augmentation in senescence-like T cells and ameliorates lupus symptoms in lupus-prone mice [97]. Here, TNFRSF8 is linked to systemic lupus erythematosus.